Orthocell (OCC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock OCC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Guess which ASX All Ords stock is jumping 10% on exciting newsSeptember 17, 2025 | msn.comHealth Check: CSL plucks up Dutch courage with R&D partnership worth about $755mSeptember 16, 2025 | msn.comOrthocell’s Remplir used in nerve-sparing prostate cancer surgerySeptember 16, 2025 | msn.comLong Shortz with Orthocell: 81% success rate validates Remplir as US rollout acceleratesSeptember 9, 2025 | msn.comRemplir™ Study Delivers Compelling 81% Success RateSeptember 8, 2025 | finance.yahoo.comStudy shows 81pc success rate for Orthocell Remplir nerve repair productSeptember 8, 2025 | msn.comOrthocell Expands Share Base with New IssuanceSeptember 3, 2025 | tipranks.comOrthocell Full Year 2025 Earnings: AU$0.038 loss per share (vs AU$0.036 loss in FY 2024)August 31, 2025 | finance.yahoo.comOrthocell Limited Reinforces Commitment to Corporate GovernanceAugust 29, 2025 | tipranks.comOrthocell Limited Releases 2025 Corporate Governance StatementAugust 29, 2025 | tipranks.comOrthocell Ltd Updates US Commercialization Efforts at Canaccord ConferenceAugust 14, 2025 | msn.comBreak it Down: Orthocell’s Remplir builds strong US market momentumAugust 13, 2025 | msn.comOrthocell Advances US Market Penetration with Remplir™August 13, 2025 | msn.comSmall Cap Watch: Orthocell advances US rollout, Antipa adds industry veteran, European Lithium engages DFS partnerAugust 12, 2025 | proactiveinvestors.com.auHealth Check: Avita salves its wounds with a lightning $23 million raisingAugust 12, 2025 | msn.comOrthocell makes high-level boardroom appointment as it eyes US growthJuly 26, 2025 | msn.comSmall Cap Watch: Targets defined, gold delivered, drilling wraps…July 24, 2025 | proactiveinvestors.com.auBreak it Down: Orthocell books first sales revenue in US for RemplirJuly 10, 2025 | msn.comOrthocell Issues New Shares to Bolster Market PositionJuly 10, 2025 | tipranks.comBiocurious: Nerve repair champion Orthocell is taking it slow and steady in the US fast laneJuly 9, 2025 | msn.comWhich ASX All Ords stock is jumping on record quarter?June 30, 2025 | msn.comGuess which ASX All Ords stock is jumping 9% on $1.6b market opportunityJune 26, 2025 | msn.comOrthocell sees 4% jump as Remplir used in first US surgery. But is that low?June 26, 2025 | msn.comHealth Check: On Garfield the Cat Day, the biotech sector purrs with deals and breakthroughsJune 19, 2025 | msn.comOrthocell sets new benchmark in nerve repairJune 19, 2025 | msn.comOrthocell’s Remplir Outperforms Standard Nerve Repair Techniques in New StudyJune 18, 2025 | tipranks.comOrthocell grows US distributors for nerve repair product to 12May 15, 2025 | msn.comHealth Check: Greenland and Canada can wait; Trump declares war on drug prices insteadMay 12, 2025 | msn.comOrthocell gains approval in key Hong Kong market for flagship nerve repair productMay 12, 2025 | msn.comOrthocell Expands Remplir™ Sales to Hong Kong with New Regulatory ApprovalMay 11, 2025 | tipranks.comWhy is this ASX All Ords stock jumping 7% today?May 9, 2025 | msn.comOrthocell secures third global approval in April for Remplir, adds Canada to growing listApril 30, 2025 | msn.comLong Shortz with Orthocell: Adding Canada to its distribution listApril 30, 2025 | msn.comOrthocell Gains Health Canada Approval for Nerve Repair Product RemplirApril 29, 2025 | tipranks.comOrthocell gains approval in Thailand for flagship nerve repair productApril 29, 2025 | msn.comOrthocell Limited Requests Trading Halt for Pending AnnouncementApril 29, 2025 | tipranks.comOrthocell Limited Initiates Trading Halt Ahead of Major AnnouncementApril 28, 2025 | tipranks.comASX Market Close: Energy stocks lead bourse higher | April 28, 2025April 28, 2025 | msn.comStockTake: Orthocell to enter the US marketApril 23, 2025 | msn.comOrthocell sees US Remplir sales on immediate horizon as distro deal locked inApril 23, 2025 | msn.comOrthocell Expands into US Nerve Repair Market with New DistributorsApril 22, 2025 | tipranks.comHealth Check: Drug sector panic sets in at the prospect of a Trump tariff ‘pharma-geddon’April 9, 2025 | msn.comOrthocell Gains ANVISA Approval for Striate+ in Brazil, Expanding Latin American ReachApril 8, 2025 | tipranks.comLong Shortz with Orthocell: Remplir gets FDA green lightApril 8, 2025 | msn.comHealth Check: We’re ‘duty free’, declare several ASX life science companiesApril 6, 2025 | msn.comScott Power: ASX health stocks fall but… Orthocell nails its US FDA approvalApril 5, 2025 | msn.comLunch Wrap: Tariff storm sinks ASX again, but Orthocell powers ahead with FDA approvalApril 4, 2025 | msn.comLevel achieved: Orthocell gains FDA approval for flagship nerve repair productApril 4, 2025 | msn.comThis company has entered a trading halt, is it about to announce FDA approval?April 3, 2025 | msn.comOrthocell Secures US FDA Clearance for Remplir Nerve Repair ProductApril 3, 2025 | tipranks.com Get Orthocell News Delivered to You Automatically Sign up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OCC Media Mentions By Week OCC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCC News Sentiment▼0.130.76▲Average Medical News Sentiment OCC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCC Articles This Week▼32▲OCC Articles Average Week Get the Latest News and Ratings for OCC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Orthocell and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Steel Partners News Today United States Antimony News Today Metallus News Today Algoma Steel Group News Today Luda Technology Group News Today HUHUTECH International Group News Today Friedman Industries News Today Webco Industries News Today Ascent Industries News Today Crystal Amber News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:OCC) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthocell Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthocell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCC Stock Alerts